An analysis of annual premiums by federal poverty level.
Oliver Wyman Actuarial Consulting discusses CMS changes for 2020.
Oliver Wyman Actuarial Consulting analyzes what happens after manufacturer costs for brand drugs change hands.
We reviewed the approaches State legislators took to offset the effect of defunding CSRs. Here are our observations of activity across the country.
Why are premiums rising amidst the Affordable Care Act market? It's not because of medical trends, says Oliver Wyman's 2018 Carrier Trend Survey.
Here’s more on how proposed modifications to CMS’ Advance Notice Summary may affect reimbursement, payment growth rates, and regulation.
Oliver Wyman's analysis of small group market risk adjustment examines past formulas, models, and systems to predict the future.
Based on our analysis recently featured in the Wall Street Journal, the prevalence of no cost bronze coverage has increased significantly for 2018.
The compromise bill may help stabilize the once shaky ACA, but here’s why this bill still demands even greater change moving forward.
What lies ahead for insurers as the ACA 2018 open enrollment period approaches.